Navigating the unique CMC challenges of oral anaerobic live biotherapeutics
European Pharmaceutical Review
FEBRUARY 14, 2024
Instead, such products are hypothesised to interact with a complex array of localised factors relating to the microbial secretome, 2 quorum-sensing networks 3 and mucosal interactions relating to various gut-host benefits. Ryan Wilson is Head of Microbiome Services at SGS Quay Pharma. Available from: [link] 2. cited 2023Nov].
77 
Let's personalize your content